Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

Cytokeratin 10/13 antibody

Antigen

Cytokeratin 10/13

Clonality Monoclonal (DE-K13)
Host
Alternatives

Mouse

Reactivity
Alternatives

Human

Application
Alternatives Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Catalog no. ABIN125129
Quantity 500ul  (100ug/ml approximately)  (Variants)
Price 217.00 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 5 Business Days

Additional Information

Alternative name Cytokeratin 10 & 13
Immunogen BALB/C mice were immunized with detergent insoluble extract of human epidermis.
Format Supernatant
Isotype IgG2a kappa  (Matching secondary antibodies)
Clone DE-K13
Specificity This antibody recognizes keratin polypeptides of 53 and 56.5KD. It stains suprabasal cells in the epidermis, thymic Hassal's bodies, urothelium and non-cornifying stratified epithelia of vagina, ectocervix, tongue and esophagus. This antibody does not stain intraepithelial neoplasm and invasive squamous cell carcinoma.

Application Details

Application Notes Titer/Working Dilution: This antibody may be diluted to a titer of 1:25-1:50 in an ABC method. However, depending on the staining conditions employed, we suggest that final dilution should be determined by the user. Staining Protocol: We suggest an incubation period of 30 minutes at room temperature. However, depending upon the fixation conditions and the staining system employed, optimal incubation should be determined by the user. Enzymatic predigestion of paraffin embedded tissues is not recommended prior to the immunostaining, as it may reduce the staining. Positive Control: Skin. Cellular localization: Cytoplasmic
Concentration 100ug/ml approximately
Buffer This antibody is supplied as tissue culture supernatant containing sodium azide as preservative.
Storage Store the antibody at 2-8o c. Do not use it beyond the expiration date stated on the label.
Research Area Extracellular Matrix
Restrictions For Research Use. CE-certified for In Vitro Diagnostics (IVD) Use in the European Union